Saumya RamaRao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Saumya RamaRao has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Anrudh K. Jain
Population Council, New York, USA
3 shared publications Wilson Liambila
Populat Council, Country Strategy, 1230 York Ave, New York, NY 10021 USA
3 shared publicationsAnrudh Jain
Acting Vice President, Population Council, New York
2 shared publicationsDeepa Rajamani
Populat Council, Country Strategy, 1230 York Ave, New York, NY 10021 USA
2 shared publicationsHarriet Birungi
Populat Council, Country Strategy, 1230 York Ave, New York, NY 10021 USA
2 shared publicationsHeather Clark
Populat Council, Country Strategy, 1230 York Ave, New York, NY 10021 USA
2 shared publications
Latest Publications
- Open Access
- 5 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 6) , e022359
Moving self-care from concept to practice
Following the publication of the WHO guidelines on self-care interventions for sexual and reproductive health (SRH) in 2019, countries have begun to recognise the value of self-care to the health system and to incorporate it into their healthcare policies and service delivery guidelines. 1 Self-care supports health systems to carry out their primary functions of protecting and promoting health, while empowering individuals to gain more agency over how they manage their own health.
- 5 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 6) , e022359
Open AccessMoving self-care from concept to practice
Following the publication of the WHO guidelines on self-care interventions for sexual and reproductive health (SRH) in 2019, countries have begun to recognise the value of self-care to the health system and to incorporate it into their healthcare policies and service delivery guidelines. 1 Self-care supports health systems to carry out their primary functions of protecting and promoting health, while empowering individuals to gain more agency over how they manage their own health.
- 1 June 2025
- Published by Wiley in Studies in Family Planning
- Vol. 56 (2) , 169-176
People, Rights, and Choices: Keeping the Promise of the ICPD Programme of Action Alive
- 1 June 2025
- Published by Wiley in Studies in Family Planning
- Vol. 56 (2) , 169-176
People, Rights, and Choices: Keeping the Promise of the ICPD Programme of Action Alive
- 5 May 2025
- Published by Wiley in Studies in Family Planning
- Vol. 56 (2) , 317-331
Big Data and AI in Sexual and Reproductive Health: A Comment
Big data and artificial intelligence (AI) have the potential to transform sexual and reproductive health (SRH), offering new avenues to enhance access, efficiency, and personalization in healthcare. AI‐driven tools can provide opportunities to improve service delivery and optimize resource allocation. Through data‐driven insights, healthcare providers can better understand population trends, predict health risks, and tailor interventions for diverse communities, ultimately advancing gender equality and empowerment. However, the integration of AI into SRH also presents significant challenges. Ethical concerns such as informed consent, data privacy, and transparency are critical to ensuring that AI applications do not violate individual autonomy and rights. The digital divide—disparities in technology access between different regions and populations—further risks exacerbating inequalities in SRH services and the provision of care. Moreover, there is a need for robust governance frameworks and global data protection laws to regulate the use of AI in SRH, and in healthcare more broadly. Programs and policies must focus on bridging these gaps, emphasizing equity and ethical considerations while leveraging AI's potential to enhance SRH services and support the vision of SRH and rights for all.
- 5 May 2025
- Published by Wiley in Studies in Family Planning
- Vol. 56 (2) , 317-331
Big Data and AI in Sexual and Reproductive Health: A Comment
Big data and artificial intelligence (AI) have the potential to transform sexual and reproductive health (SRH), offering new avenues to enhance access, efficiency, and personalization in healthcare. AI‐driven tools can provide opportunities to improve service delivery and optimize resource allocation. Through data‐driven insights, healthcare providers can better understand population trends, predict health risks, and tailor interventions for diverse communities, ultimately advancing gender equality and empowerment. However, the integration of AI into SRH also presents significant challenges. Ethical concerns such as informed consent, data privacy, and transparency are critical to ensuring that AI applications do not violate individual autonomy and rights. The digital divide—disparities in technology access between different regions and populations—further risks exacerbating inequalities in SRH services and the provision of care. Moreover, there is a need for robust governance frameworks and global data protection laws to regulate the use of AI in SRH, and in healthcare more broadly. Programs and policies must focus on bridging these gaps, emphasizing equity and ethical considerations while leveraging AI's potential to enhance SRH services and support the vision of SRH and rights for all.
- Open Access
- 18 July 2023
- Published by Wiley in Studies in Family Planning
- Vol. 54 (3) , 523-538
Feasibility and Acceptability of LNG 1.5 mg as an On‐Demand Pericoital Contraceptive in Ghana
Globally, there is a need for more family planning method options as currently, available options do not adequately meet the needs of women, specifically those who have infrequent sex. Levonorgestrel (LNG) 1.5 mg is widely available as emergency contraception pills (ECP), and recent research has shown that certain women take it as their main form of contraception. Furthermore, limited studies have found repeat, on‐demand use safe and efficacious.This 12‐month prospective, single‐arm, interventional study in Ghana tested whether a single LNG 1.5 mg on‐demand or pericoital (“around the time of sex”) dose contraceptive was acceptable to women who have infrequent sex and if pharmacy provision was feasible. The study sample (1,890) comprised women of reproductive age recruited from urban areas, having infrequent sex (i.e., coital frequency ≤ 6× per month), and not using any other modern methods except condoms or ECP at the time of study inclusion.Results indicated that there is demand and acceptability for a pericoital pill and that pharmacy provision is feasible. Furthermore, precoital use of the pill had high levels of satisfaction and was popular with new users. Adding LNG 1.5 mg for pericoital use to the family planning method mix has the potential to address an important segment of the population currently underserved, decrease unwanted pregnancies, and increase modern contraceptive prevalence rates.
- 18 July 2023
- Published by Wiley in Studies in Family Planning
- Vol. 54 (3) , 523-538
Open AccessFeasibility and Acceptability of LNG 1.5 mg as an On‐Demand Pericoital Contraceptive in Ghana
Globally, there is a need for more family planning method options as currently, available options do not adequately meet the needs of women, specifically those who have infrequent sex. Levonorgestrel (LNG) 1.5 mg is widely available as emergency contraception pills (ECP), and recent research has shown that certain women take it as their main form of contraception. Furthermore, limited studies have found repeat, on‐demand use safe and efficacious.This 12‐month prospective, single‐arm, interventional study in Ghana tested whether a single LNG 1.5 mg on‐demand or pericoital (“around the time of sex”) dose contraceptive was acceptable to women who have infrequent sex and if pharmacy provision was feasible. The study sample (1,890) comprised women of reproductive age recruited from urban areas, having infrequent sex (i.e., coital frequency ≤ 6× per month), and not using any other modern methods except condoms or ECP at the time of study inclusion.Results indicated that there is demand and acceptability for a pericoital pill and that pharmacy provision is feasible. Furthermore, precoital use of the pill had high levels of satisfaction and was popular with new users. Adding LNG 1.5 mg for pericoital use to the family planning method mix has the potential to address an important segment of the population currently underserved, decrease unwanted pregnancies, and increase modern contraceptive prevalence rates.
- Open Access
- 1 January 2022
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 29 (2) , 2040775
Setting up a research agenda for financing sexual and reproductive health services toward achieving universal health coverage in South Asia
2019 marked the twenty-fifth anniversary of the International Conference on Population and Development Programme of Action, where 179 countries committed to advance sexual and reproductive health (...
- 1 January 2022
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 29 (2) , 2040775
Open AccessSetting up a research agenda for financing sexual and reproductive health services toward achieving universal health coverage in South Asia
2019 marked the twenty-fifth anniversary of the International Conference on Population and Development Programme of Action, where 179 countries committed to advance sexual and reproductive health (...
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 14, 1761-1770
Choosing and Using the Progesterone Vaginal Ring: Women's Lived Experiences in Three African Cities
Purpose: This study explored experiences of selecting and utilizing a newly introduced contraceptive - the progesterone vaginal ring (PVR) - among women seeking a contraceptive method in 3 African capital cities (Abuja, Nairobi, and Senegal). The study explored women's perceptions of, and lived experiences with, using the new product to better understand their reception of a new contraceptive. This understanding will help inform the design of programs to support women in their adoption and continued use of the PVR and other new contraceptives. Patients and Methods: This longitudinal, qualitative study drew on an interpretive phenomenological approach, involving multiple in-depth interviews (IDIs) with 9 study participants over a 6-month period. Participants involved in the study were postpartum women seeking contraceptive services at participating clinics. A total of 25 IDIs were conducted, and a detailed "within-case" and "cross-case" analysis of participants' accounts was carried out to identify similar and dissimilar themes along descriptive, linguistic, and conceptual lines. Results: Four overarching themes emerged from the analysis. These themes circulated around the unconventionality of the PVR, which heightened its desirability among participants; the sense of comfort that women gained from opting to use the PVR over other FP methods; narratives of consideration that centered on women's partners, and that were important for ensuring the sustainability of women's PVR use; and the conundrums that women grappled with as they prepared to disengage from the PVR after two cycles of use. Conclusion: The PVR is an acceptable contraceptive method to postpartum women in urban African settings. However, prior to its introduction into new country contexts, formative data on women's perceptions of, and reactions to, the product need to inform country preparation processes. Such information would be useful for tailoring counseling around this contraceptive, as well as for product marketing and robust uptake of the method.
- 1 January 2020
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 14, 1761-1770
Open AccessChoosing and Using the Progesterone Vaginal Ring: Women's Lived Experiences in Three African Cities
Purpose: This study explored experiences of selecting and utilizing a newly introduced contraceptive - the progesterone vaginal ring (PVR) - among women seeking a contraceptive method in 3 African capital cities (Abuja, Nairobi, and Senegal). The study explored women's perceptions of, and lived experiences with, using the new product to better understand their reception of a new contraceptive. This understanding will help inform the design of programs to support women in their adoption and continued use of the PVR and other new contraceptives. Patients and Methods: This longitudinal, qualitative study drew on an interpretive phenomenological approach, involving multiple in-depth interviews (IDIs) with 9 study participants over a 6-month period. Participants involved in the study were postpartum women seeking contraceptive services at participating clinics. A total of 25 IDIs were conducted, and a detailed "within-case" and "cross-case" analysis of participants' accounts was carried out to identify similar and dissimilar themes along descriptive, linguistic, and conceptual lines. Results: Four overarching themes emerged from the analysis. These themes circulated around the unconventionality of the PVR, which heightened its desirability among participants; the sense of comfort that women gained from opting to use the PVR over other FP methods; narratives of consideration that centered on women's partners, and that were important for ensuring the sustainability of women's PVR use; and the conundrums that women grappled with as they prepared to disengage from the PVR after two cycles of use. Conclusion: The PVR is an acceptable contraceptive method to postpartum women in urban African settings. However, prior to its introduction into new country contexts, formative data on women's perceptions of, and reactions to, the product need to inform country preparation processes. Such information would be useful for tailoring counseling around this contraceptive, as well as for product marketing and robust uptake of the method.
- 2 February 2018
- Published by Wiley in Studies in Family Planning
- Vol. 49 (1) , 71-86
Do Women Find the Progesterone Vaginal Ring Acceptable? Findings from Kenya, Nigeria, and Senegal
The progesterone vaginal ring (PVR) is a contraceptive designed for use by breastfeeding women in the first year postpartum. This Report presents results of an acceptability study of the PVR in Kenya, Nigeria, and Senegal. Women seeking postpartum family planning services were offered various contraceptive options including the PVR. Of the 174 participating women, 110 (63 percent) used one ring and 94 (54 percent) completed the study by using two rings over a six-month period. Women were interviewed up to three times: at the time they entered the study, at 3 months (the end of the first ring cycle), and at 6 months (the end of the second ring cycle or when they exited if they had discontinued earlier). Many participants found the ring to be acceptable, with over three-quarters reporting that it was easy to insert, remove, and reinsert. While a small proportion of women experienced ring expulsion, the majority did not. These findings suggest that even in countries with little or no use of vaginal health products, contraceptive vaginal rings offer women a new option that they are able and willing to use.
- 2 February 2018
- Published by Wiley in Studies in Family Planning
- Vol. 49 (1) , 71-86
Do Women Find the Progesterone Vaginal Ring Acceptable? Findings from Kenya, Nigeria, and Senegal
The progesterone vaginal ring (PVR) is a contraceptive designed for use by breastfeeding women in the first year postpartum. This Report presents results of an acceptability study of the PVR in Kenya, Nigeria, and Senegal. Women seeking postpartum family planning services were offered various contraceptive options including the PVR. Of the 174 participating women, 110 (63 percent) used one ring and 94 (54 percent) completed the study by using two rings over a six-month period. Women were interviewed up to three times: at the time they entered the study, at 3 months (the end of the first ring cycle), and at 6 months (the end of the second ring cycle or when they exited if they had discontinued earlier). Many participants found the ring to be acceptable, with over three-quarters reporting that it was easy to insert, remove, and reinsert. While a small proportion of women experienced ring expulsion, the majority did not. These findings suggest that even in countries with little or no use of vaginal health products, contraceptive vaginal rings offer women a new option that they are able and willing to use.
- Open Access
- 18 August 2016
- Published by European Medical Group in EMJ Reproductive Health
- Vol. 2 (1) , 66-72
Risk of Pregnancy in Breastfeeding Mothers: Role of the Progesterone Vaginal Ring on Birth Spacing
The progesterone vaginal ring (PVR) Progering® has been shown to be effective as a contraceptive in breastfeeding women who need safe and effective...
- 18 August 2016
- Published by European Medical Group in EMJ Reproductive Health
- Vol. 2 (1) , 66-72
Open AccessRisk of Pregnancy in Breastfeeding Mothers: Role of the Progesterone Vaginal Ring on Birth Spacing
The progesterone vaginal ring (PVR) Progering® has been shown to be effective as a contraceptive in breastfeeding women who need safe and effective...
- Open Access
- 1 September 2015
- Published by Taylor & Francis in Open Access Journal of Contraception
- Vol. ume 6, 117-123
Enhancing contraceptive choice for postpartum women in sub-Saharan Africa with the progesterone vaginal ring: a review of the evidence
It is increasingly recognized that women who have just given birth have a high unmet need and require contraceptive protection in the first year postpartum. A majority of women in developing countries do breastfeed exclusively but for short durations, hence they may be sometimes unknowingly exposed to the risk of pregnancy if they are relying on nursing for contraceptive protection. The WHO’s Medical Eligibility Criteria for Contraceptive Use recommends the use of different contraceptives in the first year postpartum depending on whether the woman is nursing or not and the time since delivery. Some of the options available for breastfeeding women include implants, IUDs and injectables, which can be obtained only from a trained family planning provider. Since 2013, Population Council has been carrying out a study in Senegal, Nigeria, and Kenya to assess the acceptability of progesterone vaginal ring (PVR) as a new contraceptive option designed specifically for use by breastfeeding women to extend the period of lactational amenorrhea and promote birth spacing. Breastfeeding in sub-Saharan Africa is near universal with fairly long durations, a situation that increases the effectiveness of PVR. Each ring delivers a daily dose of 10 mg of progesterone and can be used continuously up to 3 months with a woman being able to continue with its use up to 1 year (four rings used consecutively). Preliminary results indicate that many women who had used the method found it acceptable and their partners supported its use. Activities aimed at having PVR registered and made available in focal countries are ongoing. Integration of family planning and immunization services for mothers and their newborns will be a key strategy in introducing PVR into targeted health care markets. Given that the use of PVR does not require extensive clinical training, it will be easier to integrate it at all levels of the health system from tertiary health facilities to community-based services. The PVR has been recently included in the WHO Model List of Essential Medicines and the WHO’s fifth edition of the Medical Eligibility Criteria for Contraceptive Use which should facilitate its introduction into the public and private sectors.
- 1 September 2015
- Published by Taylor & Francis in Open Access Journal of Contraception
- Vol. ume 6, 117-123
Open AccessEnhancing contraceptive choice for postpartum women in sub-Saharan Africa with the progesterone vaginal ring: a review of the evidence
It is increasingly recognized that women who have just given birth have a high unmet need and require contraceptive protection in the first year postpartum. A majority of women in developing countries do breastfeed exclusively but for short durations, hence they may be sometimes unknowingly exposed to the risk of pregnancy if they are relying on nursing for contraceptive protection. The WHO’s Medical Eligibility Criteria for Contraceptive Use recommends the use of different contraceptives in the first year postpartum depending on whether the woman is nursing or not and the time since delivery. Some of the options available for breastfeeding women include implants, IUDs and injectables, which can be obtained only from a trained family planning provider. Since 2013, Population Council has been carrying out a study in Senegal, Nigeria, and Kenya to assess the acceptability of progesterone vaginal ring (PVR) as a new contraceptive option designed specifically for use by breastfeeding women to extend the period of lactational amenorrhea and promote birth spacing. Breastfeeding in sub-Saharan Africa is near universal with fairly long durations, a situation that increases the effectiveness of PVR. Each ring delivers a daily dose of 10 mg of progesterone and can be used continuously up to 3 months with a woman being able to continue with its use up to 1 year (four rings used consecutively). Preliminary results indicate that many women who had used the method found it acceptable and their partners supported its use. Activities aimed at having PVR registered and made available in focal countries are ongoing. Integration of family planning and immunization services for mothers and their newborns will be a key strategy in introducing PVR into targeted health care markets. Given that the use of PVR does not require extensive clinical training, it will be easier to integrate it at all levels of the health system from tertiary health facilities to community-based services. The PVR has been recently included in the WHO Model List of Essential Medicines and the WHO’s fifth edition of the Medical Eligibility Criteria for Contraceptive Use which should facilitate its introduction into the public and private sectors.
- 10 March 2015
- Published by Wiley in Studies in Family Planning
- Vol. 46 (1) , 97-104
Aligning Goals, Intents, and Performance Indicators in Family Planning Service Delivery
A flurry of policy initiatives in the fields of both population and development and reproductive health, many addressing the provision of family planning services, are currently underway: FP2020, the ICPD Beyond 2014, and the post-2015 development agenda, among others. This is an opportune time, therefore, to reflect upon and take into consideration what five decades of family planning programs can teach us about ensuring that policies and programs integrate their underlying intents, concrete goals, and performance indicators. The family planning field has encountered instances in its history when inconsistencies between goals, intents, and indicators arose and adversely affected the delivery of services. This commentary presents our observations concerning potential misalignments that may arise within the many promising initiatives underway. We examine the relationship between the intent, goal, and indicators of FP2020 as a case study highlighting the need for ensuring a tight alignment. We offer suggestions for ensuring that this and other initiatives use carefully calibrated indicators to guide the achievement of explicit program goals without undermining their underlying intent-namely, promoting well-being and reproductive rights.
- 10 March 2015
- Published by Wiley in Studies in Family Planning
- Vol. 46 (1) , 97-104
Aligning Goals, Intents, and Performance Indicators in Family Planning Service Delivery
A flurry of policy initiatives in the fields of both population and development and reproductive health, many addressing the provision of family planning services, are currently underway: FP2020, the ICPD Beyond 2014, and the post-2015 development agenda, among others. This is an opportune time, therefore, to reflect upon and take into consideration what five decades of family planning programs can teach us about ensuring that policies and programs integrate their underlying intents, concrete goals, and performance indicators. The family planning field has encountered instances in its history when inconsistencies between goals, intents, and indicators arose and adversely affected the delivery of services. This commentary presents our observations concerning potential misalignments that may arise within the many promising initiatives underway. We examine the relationship between the intent, goal, and indicators of FP2020 as a case study highlighting the need for ensuring a tight alignment. We offer suggestions for ensuring that this and other initiatives use carefully calibrated indicators to guide the achievement of explicit program goals without undermining their underlying intent-namely, promoting well-being and reproductive rights.